Zenotech Laboratories share news and announcements
BSE: 532039Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹39.50.
- Next results date: the board meets on 28 Oct 2026 to consider: quarterly results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹246 Cr2,190th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 29 Apr 2026
- 2.6
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 28 Jul 2026
- −2.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 28 Jul 2026
- −3.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 Apr 2026
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day.
- 3,902
Zenotech Laboratories share news and announcements
494 announcements, routine notices left out, newest first. Page 2 of 10.
Jan 2025
20 Jan · Board meeting
Meeting on 28 Jan 2025: quarterly results
Oct 2024
17 Oct · Board meeting
Meeting on 23 Oct 2024: quarterly results
Sep 2024
11 Sep · Legal
Exchange has sought clarification from Zenotech Laboratories Ltd on September 11, 2024 with reference to significant movement in price, in order to ensure that investors have latest ....
Aug 2024
Jul 2024
26 Jul · Board meeting
26 Jul · Results
25 Jul · Management
18 Jul · Board meeting
Meeting on 26 Jul 2024: quarterly results
May 2024
Apr 2024
24 Apr · Board meeting
Meeting on 1 May 2024: audited results24 Apr · Compliance Certificate Under Regulation 40(9) & (10) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
6 Apr · Compliance Certificate Pursuant To Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended March 31, 2024
6 Apr · Meeting
Jan 2024
17 Jan · Board meeting
Meeting on 29 Jan 2024: quarterly results
Oct 2023
20 Oct · Board meeting
Meeting on 30 Oct 2023: quarterly results
Sep 2023
Aug 2023
18 Aug · Legal
Jul 2023
25 Jul · Board meeting
Meeting on 1 Aug 2023: quarterly results
May 2023
31 May · Reminder Letter To Holders Of Physical Securities For Furnishing Of PAN, KYC Details And Nomination Details As Per SEBI Circular
Apr 2023
24 Apr · Compliance Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended March 31, 2023
21 Apr · Board meeting
Meeting on 28 Apr 2023: audited results11 Apr · Compliance Certificate Pursuant To Regulation 7 (3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended - For The Financial Year Ended On March 31, 2023